SLNCF
Price
$1.60
Change
+$0.15 (+10.34%)
Updated
Oct 6 closing price
Capitalization
226.72M
SOLTF
Price
$7.00
Change
+$0.60 (+9.38%)
Updated
Oct 2 closing price
Capitalization
603.01M
Interact to see
Advertisement

SLNCF vs SOLTF

Header iconSLNCF vs SOLTF Comparison
Open Charts SLNCF vs SOLTFBanner chart's image
Silence Therapeutics
Price$1.60
Change+$0.15 (+10.34%)
Volume$501
Capitalization226.72M
Nxera Pharma
Price$7.00
Change+$0.60 (+9.38%)
Volume$100
Capitalization603.01M
SLNCF vs SOLTF Comparison Chart in %
SLNCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SOLTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SLNCF vs. SOLTF commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SLNCF is a Hold and SOLTF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 09, 2025
Stock price -- (SLNCF: $1.60 vs. SOLTF: $7.00)
Brand notoriety: SLNCF and SOLTF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SLNCF: 86% vs. SOLTF: 10%
Market capitalization -- SLNCF: $226.72M vs. SOLTF: $603.01M
SLNCF [@Biotechnology] is valued at $226.72M. SOLTF’s [@Biotechnology] market capitalization is $603.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SLNCF’s FA Score shows that 1 FA rating(s) are green whileSOLTF’s FA Score has 0 green FA rating(s).

  • SLNCF’s FA Score: 1 green, 4 red.
  • SOLTF’s FA Score: 0 green, 5 red.
According to our system of comparison, SLNCF is a better buy in the long-term than SOLTF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SLNCF’s TA Score shows that 4 TA indicator(s) are bullish while SOLTF’s TA Score has 5 bullish TA indicator(s).

  • SLNCF’s TA Score: 4 bullish, 3 bearish.
  • SOLTF’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both SLNCF and SOLTF are a good buy in the short-term.

Price Growth

SLNCF (@Biotechnology) experienced а +10.34% price change this week, while SOLTF (@Biotechnology) price change was +9.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.11%. For the same industry, the average monthly price growth was +19.03%, and the average quarterly price growth was +87.04%.

Industries' Descriptions

@Biotechnology (+9.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SOLTF($603M) has a higher market cap than SLNCF($227M). SOLTF YTD gains are higher at: 13.683 vs. SLNCF (-39.048). SOLTF has higher annual earnings (EBITDA): 854M vs. SLNCF (-84.82M). SOLTF has more cash in the bank: 33B vs. SLNCF (114M). SLNCF has less debt than SOLTF: SLNCF (0) vs SOLTF (64.7B). SOLTF has higher revenues than SLNCF: SOLTF (31.2B) vs SLNCF (27.2M).
SLNCFSOLTFSLNCF / SOLTF
Capitalization227M603M38%
EBITDA-84.82M854M-10%
Gain YTD-39.04813.683-285%
P/E RatioN/AN/A-
Revenue27.2M31.2B0%
Total Cash114M33B0%
Total Debt064.7B-
FUNDAMENTALS RATINGS
SLNCF vs SOLTF: Fundamental Ratings
SLNCF
SOLTF
OUTLOOK RATING
1..100
9584
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
92
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
5051
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SLNCF's Valuation (24) in the null industry is significantly better than the same rating for SOLTF (92). This means that SLNCF’s stock grew significantly faster than SOLTF’s over the last 12 months.

SLNCF's Profit vs Risk Rating (100) in the null industry is in the same range as SOLTF (100). This means that SLNCF’s stock grew similarly to SOLTF’s over the last 12 months.

SLNCF's SMR Rating (98) in the null industry is in the same range as SOLTF (98). This means that SLNCF’s stock grew similarly to SOLTF’s over the last 12 months.

SLNCF's Price Growth Rating (50) in the null industry is in the same range as SOLTF (51). This means that SLNCF’s stock grew similarly to SOLTF’s over the last 12 months.

SLNCF's P/E Growth Rating (100) in the null industry is in the same range as SOLTF (100). This means that SLNCF’s stock grew similarly to SOLTF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SLNCFSOLTF
RSI
ODDS (%)
Bullish Trend 2 days ago
56%
Bearish Trend 2 days ago
57%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
49%
Momentum
ODDS (%)
Bullish Trend 2 days ago
49%
Bearish Trend 2 days ago
56%
MACD
ODDS (%)
Bullish Trend 2 days ago
57%
Bearish Trend 2 days ago
47%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 2 days ago
36%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
56%
Bullish Trend 2 days ago
33%
Advances
ODDS (%)
N/A
Bullish Trend 20 days ago
55%
Declines
ODDS (%)
N/A
Bearish Trend 13 days ago
43%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
67%
Aroon
ODDS (%)
Bearish Trend 2 days ago
68%
Bullish Trend 2 days ago
25%
View a ticker or compare two or three
Interact to see
Advertisement
SLNCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SOLTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FEQTX30.21N/A
N/A
Fidelity Equity Dividend Income
NOSGX14.11N/A
N/A
Northern Small Cap Value
MBVKX20.92N/A
N/A
BlackRock Large Cap Focus Value K
CEIIX13.58N/A
N/A
Manning & Napier Callodine Equity Inc I
NWAKX24.84N/A
N/A
Nationwide Janus Henderson Ovrs InsSvc

SLNCF and

Correlation & Price change

A.I.dvisor tells us that SLNCF and ENVB have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SLNCF and ENVB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLNCF
1D Price
Change %
SLNCF100%
N/A
ENVB - SLNCF
29%
Poorly correlated
+0.46%
RNXT - SLNCF
24%
Poorly correlated
-8.96%
QLGN - SLNCF
21%
Poorly correlated
N/A
SOLTF - SLNCF
9%
Poorly correlated
N/A
PVCT - SLNCF
8%
Poorly correlated
-0.65%
More

SOLTF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SOLTF has been loosely correlated with BIESF. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if SOLTF jumps, then BIESF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SOLTF
1D Price
Change %
SOLTF100%
N/A
BIESF - SOLTF
35%
Loosely correlated
N/A
BSFAF - SOLTF
29%
Poorly correlated
N/A
SPHRF - SOLTF
23%
Poorly correlated
+4.76%
SLNCF - SOLTF
9%
Poorly correlated
N/A
SPHDF - SOLTF
5%
Poorly correlated
N/A
More